Butterfly Network (BFLY) Competitors $1.96 -0.12 (-5.56%) Closing price 09/25/2025 03:59 PM EasternExtended Trading$1.94 -0.02 (-0.77%) As of 09/25/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFLY vs. NVCR, CDRE, BLFS, BBNX, SSII, KMTS, ESTA, MDXG, PLSE, and INMDShould you be buying Butterfly Network stock or one of its competitors? The main competitors of Butterfly Network include NovoCure (NVCR), Cadre (CDRE), BioLife Solutions (BLFS), Beta Bionics (BBNX), SS Innovations International (SSII), Kestra Medical Technologies (KMTS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), and InMode (INMD). These companies are all part of the "medical equipment" industry. Butterfly Network vs. Its Competitors NovoCure Cadre BioLife Solutions Beta Bionics SS Innovations International Kestra Medical Technologies Establishment Labs MiMedx Group Pulse Biosciences InMode NovoCure (NASDAQ:NVCR) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations. Is NVCR or BFLY more profitable? NovoCure has a net margin of -27.13% compared to Butterfly Network's net margin of -71.79%. Butterfly Network's return on equity of -30.53% beat NovoCure's return on equity.Company Net Margins Return on Equity Return on Assets NovoCure-27.13% -47.74% -13.79% Butterfly Network -71.79%-30.53%-21.80% Do analysts prefer NVCR or BFLY? NovoCure presently has a consensus price target of $28.79, suggesting a potential upside of 125.24%. Butterfly Network has a consensus price target of $3.00, suggesting a potential upside of 53.45%. Given NovoCure's higher possible upside, analysts plainly believe NovoCure is more favorable than Butterfly Network.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NovoCure 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Butterfly Network 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media refer more to NVCR or BFLY? In the previous week, Butterfly Network had 6 more articles in the media than NovoCure. MarketBeat recorded 8 mentions for Butterfly Network and 2 mentions for NovoCure. NovoCure's average media sentiment score of 1.79 beat Butterfly Network's score of 0.51 indicating that NovoCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Butterfly Network 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation & earnings, NVCR or BFLY? Butterfly Network has lower revenue, but higher earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovoCure$605.22M2.36-$168.63M-$1.56-8.19Butterfly Network$82.06M6.00-$72.49M-$0.28-6.98 Which has more risk & volatility, NVCR or BFLY? NovoCure has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500. Do institutionals and insiders have more ownership in NVCR or BFLY? 84.6% of NovoCure shares are owned by institutional investors. Comparatively, 37.9% of Butterfly Network shares are owned by institutional investors. 5.5% of NovoCure shares are owned by company insiders. Comparatively, 25.2% of Butterfly Network shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryButterfly Network beats NovoCure on 9 of the 16 factors compared between the two stocks. Get Butterfly Network News Delivered to You Automatically Sign up to receive the latest news and ratings for BFLY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFLY vs. The Competition Export to ExcelMetricButterfly NetworkMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$521.10M$2.13B$5.75B$21.61BDividend YieldN/AN/A5.75%3.52%P/E Ratio-6.9836.0275.7729.18Price / Sales6.0010.67544.6259.53Price / CashN/A58.9837.5424.32Price / Book2.4710.8312.874.52Net Income-$72.49M-$63.46M$3.29B$1.00B7 Day Performance5.39%0.23%0.28%-0.84%1 Month Performance23.34%-0.96%2.87%1.80%1 Year Performance29.04%33.37%65.66%12.54% Butterfly Network Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFLYButterfly Network3.2518 of 5 stars$1.96-5.6%$3.00+53.5%+26.9%$521.10M$82.06M-6.98460Gap UpNVCRNovoCure4.3186 of 5 stars$12.72+4.7%$28.79+126.3%-19.9%$1.36B$605.22M-8.151,488Positive NewsCDRECadre1.9284 of 5 stars$32.72+0.6%$31.50-3.7%-4.4%$1.32B$567.56M34.812,284Positive NewsBLFSBioLife Solutions2.9581 of 5 stars$25.80+1.1%$31.29+21.3%+0.8%$1.22B$82.25M-214.98440BBNXBeta Bionics1.3204 of 5 stars$25.31-4.2%$22.56-10.9%N/A$1.15B$65.12M0.00294Analyst ForecastSSIISS Innovations InternationalN/A$5.40-6.9%N/AN/A$1.12B$20.65M0.004KMTSKestra Medical Technologies0.829 of 5 stars$22.68+3.9%$27.33+20.5%N/A$1.12B$59.81M0.00300Positive NewsHigh Trading VolumeESTAEstablishment Labs2.3419 of 5 stars$36.84-1.7%$56.50+53.4%-2.0%$1.09B$166.02M0.001,018Positive NewsMDXGMiMedx Group3.382 of 5 stars$6.97+0.4%$12.00+72.2%+19.1%$1.03B$348.88M23.13870Positive NewsPLSEPulse Biosciences4.165 of 5 stars$15.74+8.4%$22.00+39.8%+0.9%$977.14M$700K-14.99140Positive NewsInsider TradeGap UpHigh Trading VolumeINMDInMode2.7414 of 5 stars$14.86+0.2%$18.04+21.4%-10.1%$937.39M$394.82M6.02480Positive News Related Companies and Tools Related Companies NVCR Alternatives CDRE Alternatives BLFS Alternatives BBNX Alternatives SSII Alternatives KMTS Alternatives ESTA Alternatives MDXG Alternatives PLSE Alternatives INMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BFLY) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredChina Targets MAGA In Stealth Trade War TacticsChina is deliberately targeting the economic backbone of conservative America - The very industries that supp...Goldco Precious Metals | SponsoredCollege grad makes $64,000 a monthNothing hurts like a missed opportunity... And with AI stocks like Nvidia, Palantir, and Oracle continuing...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Butterfly Network, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Butterfly Network With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BFLY Stock Alerts